Key result
Zinc sulfate applied to the olfactory mucosa protects monkeys against poliomyelitis virus.
Why the study?
Chemical agents applied to the olfactory mucosa of monkeys have shown considerable protection against poliomyelitis virus, suggesting potential for human prophylaxis during outbreaks.
Does the application of chemical agents like 1% zinc sulfate to the olfactory mucosa protect against poliomyelitis infection?
Does the application of chemical agents like 1% zinc sulfate to the olfactory mucosa protect against poliomyelitis infection?
The authors propose devising a method for applying chemical prophylaxis (such as 1% zinc sulfate) to the olfactory mucosa to protect against poliomyelitis.
Answers are grounded in this paper and cite their sources.
Should not alter clinical practice; leaves open the need for human trials of zinc sulfate prophylaxis against poliomyelitis.
The observations of Armstrong and Harrison, 1 those of Sabin, Olitsky and Cox 2 and, especially, those of Schultz and Gebhardt 3 seem to show conclusively that certain chemical agents carefully applied to the olfactory mucosa of monkeys afford considerable protection against infection by subsequent intranasal instillation of poliomyelitis virus. The essential observations which have been made up to the present were summarized in a recent article by Schultz and Gebhardt 4 and therefore do not need to be repeated here. This evidence, that a chemical agent such as 1 per cent zinc sulfate confers on monkeys a high degree of resistance against poliomyelitis virus for at least one month after treatment, suggests that such a prophylactic measure may deserve a trial in human beings during periods when poliomyelitis is prevalent. We have concerned ourselves primarily with devising a method of ap- plying the prophylactic treatments that can be easily
No takes yet. Share an insight, caveat, or question.
Lee Shahinian (1938) studied Poliomyelitis. 1 per cent zinc sulfate was evaluated. Application of 1% zinc sulfate to the olfactory mucosa confers resistance against poliomyelitis virus in monkeys, suggesting it may deserve a prophylactic trial in humans.
Synapse has enriched 10 related papers. Consider them for comparative context: